Category Medicine and Healthcare
Press Release
Ovaterra’s New Advanced Prenatal Vitamins Formula Leverages the Latest Science to Meet the Nutritional Needs of Women Before, During, and After Pregnancy
Ovaterra's new formula is the first prenatal vitamin in the U.S. market to provide 100% of the essential nutrients a woman needs during pregnancy, according to the latest research. Read More
Press Release
Cybersecurity Crisis Grips Healthcare: 9 in 10 Providers Struggle to Keep Pace With Evolving Threats, Black Book Research
Despite 2023 warnings to strengthen cybersecurity defenses, ransomware attacks persist, resulting in significant financial losses, disruptions to operations, and jeopardizing patient care. Read More
Press Release
Napo Pharmaceuticals, a Jaguar Health Family Company, Sponsoring Pediatric Gastroenterology Conference in Abu Dhabi and Panel Discussion About Microvillus Inclusion Disease (MVID)
Jaguar's novel plant-based prescription drug crofelemer has been granted Orphan Drug Designation by the FDA and the European Medicines Agency for both MVID and short bowel syndrome (SBS) with intestinal failure Proof-of-concept studies of crofelemer for MVID and SBS planned for 2024 Read More
Press Release
Tharimmune Announces Option Agreement for Key Technologies for Generating HER2/HER3 Antibody Drug Conjugates (ADCs)
Obtained rights from Washington University to develop and incorporate human HER2 directed antibodies Complements early pipeline of novel tunable "Knob domain" antibodies for HER2 & HER3 Read More
Press Release
Alliance Spine and Pain Centers Implement Behavioral Health Screening With Mental Health Technologies’ Patented SmarTest™ Technology
Alliance Spine and Pain Centers automate regular behavioral health screening with MHT's patented SmarTest™ platform to address comorbidities between chronic pain and mental health concerns. Read More
Press Release
Napo Pharmaceuticals, a Jaguar Health Family Company, to Exhibit at Oncology Nursing Society (ONS) Congress in Support of Company’s Expanding Focus on Cancer Supportive Care
Jaguar planning to begin commercial launch of FDA-approved Gelclair® prescription gel for oral mucositis (also called "chemo mouth") in Q3 2024 Company to feature "Make Cancer Less Shitty" patient advocacy program at ONS Congress Read More
Press Release
Clinical Endpoint Adjudication: Ethical Enhances eAdjudication® With an Innovative AI-Powered Conversational Documents Search
By leveraging advanced natural language processing and machine learning capabilities, Ethical's new AI-powered conversational documents search tool reduces the time and effort required to find critical information and enhances the overall efficiency and quality of the endpoint adjudication process. Read More
Press Release
Connect America Unveils Next-Generation Fall Prevention Program to Help Support Aging Populations Living at Home
The industry-first program aims to address the $50B in fall-related healthcare costs for older adults through a combination of innovative connected health devices, AI virtual assistance, predictive risk analytics, and support services. Read More
Press Release
Jaguar Health Appoints Biopharmaceutical Industry Veteran to Execute Company's In-licensing Growth Strategy in the Areas of Cancer and GI Supportive Care
Catherine Miller Collis was instrumental in bringing about Jaguar's recent in-license agreement for FDA-approved Gelclair®, a protective gel for management of oral mucositis, a common, painful, and debilitating cancer treatment-related side effect Read More
Press Release
